Most Read News

Dr. Reddy’s Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.

Zydus Lifesciences announced the appointment of Pankaj R. Patel, Chairman of the company as a Part Time Non-official Director in the Central Board of the Reserve Bank of India (RBI). Powered by Capital Market – Live News

It's the most recent high-profile failure of a crypto industry pillar. These financial meltdowns have wiped out tens of billions of dollars in investor assets, prompting urgent calls for regulation of the unregulated industry.

Life Insurance Corporation of India announced the launch of Dhan Sanchay, a non-linked, non-participating, individual, savings, life insurance plan on 14 June 2022. Powered by Capital Market – Live News

The Bank is well provided and does not foresee any asset quality challenges.

Dr. Reddys Laboratories announced the launch of Dr. Reddys Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar? (sorafenib) Tablets in the U.S. market following the approval by the U.S. Food and Drug Administration (USFDA). Dr. Reddys Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120. Powered by Capital Market – Live News

Happiest Minds Technologies announced that the company was adjudged a winner at the Economic Times DataCon Awards 2022 in the category: Core Operations – Innovative Use Cases of Analytics/ AI/ ML at the award gala held at Mumbai on 9 June 2022.Powered by Capital Market – Live News

Business Wire India Ecolibrium’s Head of Commercial Real Estate Yash Kapila (left) and CEO Chintan Soni (right) will lead the business’ UK expansion from its new London HQ. Image credit: Max Lacome UK expansion builds on considerable success in Asia Pacific, where Ecolibrium’s technology has been deployed across 50 million sq ft by globally renowned brands including Amazon, Fiat, Honeywell, Thomson Reuters, Tata Power, and […]

In its monthly dealer check, IIFL Capital Services analyzes the key trends.

Life Insurance Corporation of India has hiked its shareholding in Capri Global Capital from 88,58,348 to 1,24,00,000 equity shares, thereby increasing its stake from 5.043% to 7.059% of the paid-up capital of the said Company.Powered by Capital Market – Live News